Product information

Current status:

Marketed

Current status date:

2022-03-15

Original market date: ^{See footnote 1}

2022-03-15

Product name:

RED EYE TRIPLE ACTION

DIN:

02518201 Electronic product monograph is not available

Company:

JOHNSON & JOHNSON INC
88 Mcnabb Street
Markham
Ontario
Canada L3R 5L2

Class:

Human

Dosage form(s):

Drops

Route(s) of administration:

Ophthalmic

Number of active ingredient(s):

2

Schedule(s):

OTC

American Hospital Formulary Service (AHFS): ^{See footnote 3}

52:32.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

S01GA52 TETRYZOLINE, COMBINATIONS

Active ingredient group (AIG) number:^{See footnote5}

0227167001